Trial of Single Agent Sunitinib for Patients With Chemo-refractory Metastatic Melanoma
Clinical trial NCT01216657 · TERMINATED
Trial details
- NCT number
- NCT01216657
- Sponsor
- Krankenhaus Nordwest
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2013-05-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.